[1] Yeh MW, Ituarte PH, Zhou HC, et al.Incidence and prevalence of primary hyperparathyroidism in a racially mixed population[J]. J Clin Endocrinol Metab,2013,98(3):1122-1129.
[2] Berger C, Almohareb O, Langsetmo L, et al.Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers[J]. Clin Endocrinol(Oxf),2015,82(3):359-368.
[3] Jorde R, Bønaa KH, Sundsfjord J.Primary hyperparathyroidism detected in a health screening. The Trømsø study[J]. J Clin Epidemiol,2000,53(11):1164-1169.
[4] Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years[J]. J Clin Endocrinol Metab,2008,93(9):3462-3470.
[5] Zhao L, Liu JM, He XY, et al.The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center[J]. J Clin Endocrinol Metab,2013,98(2):721-728.
[6] 廖泉, 胡亚, 赵玉沛. 小切口甲状旁腺手术[J]. 中华外科杂志,2015,53(3):164-166.
[7] Orevi M, Freedman N, Mishani E, et al.Localization of parathyroid adenoma by 11C-choline PET/CT: preliminary results[J]. Clin Nucl Med,2014,39(12):1033-1038.
[8] 中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组. 原发性甲状旁腺功能亢进症诊疗指南[J]. 中华骨质疏松和骨矿盐疾病杂志,2014,7(3):187-198.
[9] 田文, 贺青卿, 姜可伟, 等. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志,2016,36(5):481-486.
[10] 刘士豪. 甲状旁腺近期文献综述[J]. Chin Med J,1926, 12:34.
[11] 龚家镇. 甲状旁腺机能亢进[J]. 中华外科杂志,1957,5(6):515-516.
[12] 郭巨灵, 袁世祥, 张克勤, 等. 甲状旁腺机能亢进附二例临床报告[J]. 天津医药杂志,1959(3):192-196,199-200.
[13] 李秉权, 吴致勲. 甲状旁腺机能亢进综述与病例报告[J]. 云南医学杂志,1960(4):76-80.
[14] 陈曦. 甲状旁腺癌诊治难点与对策[J]. 中国实用外科杂志,2014,34(4):305-308.
